New York-based healthcare investment firm OrbiMed is raising a new private equity fund targeting $950 million, according to an SEC filing.
The vehicle, OrbiMed Private Investments VI, will be significantly larger than the firm’s last private equity fund, OrbiMed Private Investments V, a 2013-vintage fund that closed on $735 million that same year, surpassing its target of $750 million, Private Healthcare Investor reports.
To read the full article, click here.